To test this possibility, we obtained residual tumor cells from CRC cells infected with TetOn‐YY2 lentivirus by sorting living cells that survived oxaliplatin treatment, treated them with or without doxycycline to induce YY2 overexpression, and examined their viability under oxaliplatin treatment (Figure 6K). The gene discussed is YY2; the disease is colorectal carcinoma.